This inventor holds 1 USPTO granted patent. Top assignee: Kirin Beer Kabushiki Kaisha. Active years: 2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2005
Title: The Innovative Contributions of Eiji Sawa in Pharmaceutical Chemistry
Introduction: Eiji Sawa is a prominent inventor based in Gunma-ken, Japan, known for his groundbreaking work in pharmaceutical chemistry. With a keen focus on developing novel compounds, Sawa has made significant strides in the realm of medicinal chemistry, particularly in the area of receptor inhibition.
Latest Patents: Sawa holds a patent for innovative urea derivatives that serve as inhibitors for the CCR-3 receptor. The patent details how these urea and thiourea derivatives effectively inhibit cell function of the chemokine receptor CCR-3. The compounds developed offer a promising approach for treating various diseases that are believed to be mediated by this receptor. The synthesis of these compounds can be accomplished through both liquid and solid phase synthesis protocols, showcasing Sawa's versatility and creativity in the laboratory.
Career Highlights: Sawa is currently affiliated with Kirin Beer Kabushiki Kaisha, a well-respected company in the food and beverage industry. His role there has allowed him to apply his expertise in a domain that bridges chemistry and practical application, ultimately leading to significant advancements in the development of pharmaceutical agents.
Collaborations: Throughout his career, Sawa has collaborated with talented individuals such as Janak Padia and Michael Hocker. These collaborations highlight his commitment to teamwork and collective innovation, as they work together to explore the potential of various chemical compounds in medical applications.
Conclusion: Eiji Sawa's contributions to the field of pharmaceutical chemistry, particularly through his patented work on CCR-3 receptor inhibitors, reflect his dedication to innovation and improvement in medical science. His collaborations and employment with Kirin Beer Kabushiki Kaisha underscore the important relationship between scientific research and its practical applications in healthcare. Sawa's work promises to impact the treatment of diseases connected to the CCR-3 receptor, making him a notable inventor in his field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile